Rank | Gene Set | Z-score |
---|---|---|
1 | striated muscle atrophy (GO:0014891) | 9.73673268 |
2 | regulation of steroid hormone biosynthetic process (GO:0090030) | 9.39983137 |
3 | seminiferous tubule development (GO:0072520) | 9.06247889 |
4 | skeletal muscle adaptation (GO:0043501) | 8.65815340 |
5 | muscle atrophy (GO:0014889) | 8.36931697 |
6 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 8.35281781 |
7 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 8.34544160 |
8 | carnitine shuttle (GO:0006853) | 8.33444252 |
9 | uterus development (GO:0060065) | 7.07481095 |
10 | fatty acid transmembrane transport (GO:1902001) | 6.99822742 |
11 | cellular response to gonadotropin stimulus (GO:0071371) | 6.91757135 |
12 | carnitine transmembrane transport (GO:1902603) | 6.88574058 |
13 | synaptic vesicle maturation (GO:0016188) | 6.79877263 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.71871375 |
15 | DNA integration (GO:0015074) | 6.62979621 |
16 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 6.61275006 |
17 | positive regulation of cAMP-mediated signaling (GO:0043950) | 6.42180906 |
18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.24926981 |
19 | carnitine transport (GO:0015879) | 6.24897145 |
20 | amino-acid betaine transport (GO:0015838) | 6.24897145 |
21 | regulation of hormone biosynthetic process (GO:0046885) | 6.20145013 |
22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.08656980 |
23 | sulfation (GO:0051923) | 6.00791973 |
24 | locomotory exploration behavior (GO:0035641) | 5.85304106 |
25 | regulation of glycolytic process (GO:0006110) | 5.84500291 |
26 | cellular response to reactive nitrogen species (GO:1902170) | 5.82314515 |
27 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.80658459 |
28 | positive regulation of tolerance induction (GO:0002645) | 5.67883032 |
29 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.67657157 |
30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.57454094 |
31 | regulation of fatty acid oxidation (GO:0046320) | 5.56738436 |
32 | regulation of energy homeostasis (GO:2000505) | 5.52757944 |
33 | gamma-aminobutyric acid transport (GO:0015812) | 5.46942917 |
34 | positive regulation of hormone biosynthetic process (GO:0046886) | 5.43748282 |
35 | regulation of regulatory T cell differentiation (GO:0045589) | 5.41248460 |
36 | intracellular lipid transport (GO:0032365) | 5.37304199 |
37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.37262920 |
38 | positive regulation of gluconeogenesis (GO:0045722) | 5.21920289 |
39 | response to methylmercury (GO:0051597) | 5.17122813 |
40 | glutamate secretion (GO:0014047) | 5.10055725 |
41 | glucocorticoid biosynthetic process (GO:0006704) | 5.09863751 |
42 | response to muscle activity (GO:0014850) | 5.06938429 |
43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.03355599 |
44 | cellular response to dexamethasone stimulus (GO:0071549) | 4.98912079 |
45 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.97299287 |
46 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.97299287 |
47 | regulation of T cell tolerance induction (GO:0002664) | 4.96167305 |
48 | protein targeting to vacuole (GO:0006623) | 4.89397812 |
49 | protein targeting to lysosome (GO:0006622) | 4.89397812 |
50 | establishment of protein localization to vacuole (GO:0072666) | 4.89397812 |
51 | female gonad development (GO:0008585) | 4.87580336 |
52 | sodium ion export (GO:0071436) | 4.84839520 |
53 | bone resorption (GO:0045453) | 4.82708402 |
54 | flavonoid metabolic process (GO:0009812) | 4.72410079 |
55 | neurotransmitter secretion (GO:0007269) | 4.71994584 |
56 | synaptic vesicle exocytosis (GO:0016079) | 4.70653019 |
57 | vocalization behavior (GO:0071625) | 4.69986106 |
58 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.63724536 |
59 | NAD biosynthetic process (GO:0009435) | 4.62542078 |
60 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.61716519 |
61 | response to dexamethasone (GO:0071548) | 4.60204742 |
62 | male genitalia development (GO:0030539) | 4.59764850 |
63 | neuromuscular process controlling posture (GO:0050884) | 4.51798558 |
64 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.51481089 |
65 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.51050818 |
66 | regulation of hormone metabolic process (GO:0032350) | 4.50664658 |
67 | phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200) | 4.50065167 |
68 | neuron cell-cell adhesion (GO:0007158) | 4.47189774 |
69 | response to epinephrine (GO:0071871) | 4.46524232 |
70 | layer formation in cerebral cortex (GO:0021819) | 4.44163287 |
71 | cellular potassium ion homeostasis (GO:0030007) | 4.42965091 |
72 | regulation of synaptic vesicle transport (GO:1902803) | 4.41440579 |
73 | proline transport (GO:0015824) | 4.38728515 |
74 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.38210686 |
75 | response to gonadotropin (GO:0034698) | 4.34554075 |
76 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 4.33922964 |
77 | regulation of lipoprotein metabolic process (GO:0050746) | 4.33603009 |
78 | quaternary ammonium group transport (GO:0015697) | 4.30310966 |
79 | regulation of cellular carbohydrate catabolic process (GO:0043471) | 4.28805965 |
80 | regulation of carbohydrate catabolic process (GO:0043470) | 4.28805965 |
81 | regulation of collateral sprouting (GO:0048670) | 4.25935391 |
82 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.24531605 |
83 | galactose metabolic process (GO:0006012) | 4.22191146 |
84 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.21551384 |
85 | activation of protein kinase A activity (GO:0034199) | 4.19919793 |
86 | regulation of tolerance induction (GO:0002643) | 4.19881244 |
87 | positive regulation of alcohol biosynthetic process (GO:1902932) | 4.19608660 |
88 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.18108001 |
89 | exploration behavior (GO:0035640) | 4.10352903 |
90 | positive regulation of fatty acid oxidation (GO:0046321) | 4.08696254 |
91 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.07524113 |
92 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.05962339 |
93 | response to thyroid hormone (GO:0097066) | 4.04864325 |
94 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.04755737 |
95 | response to insecticide (GO:0017085) | 4.03381026 |
96 | cell communication by electrical coupling (GO:0010644) | 4.02068083 |
97 | early endosome to late endosome transport (GO:0045022) | 3.97052685 |
98 | positive regulation of hormone metabolic process (GO:0032352) | 3.94281135 |
99 | negative regulation of myoblast differentiation (GO:0045662) | 3.92900485 |
100 | neurotransmitter transport (GO:0006836) | 3.92526556 |
101 | neuronal action potential propagation (GO:0019227) | 3.91912069 |
102 | cerebellar Purkinje cell layer development (GO:0021680) | 3.91910657 |
103 | plasma membrane repair (GO:0001778) | 3.87048618 |
104 | potassium ion import (GO:0010107) | 3.81085606 |
105 | axonal fasciculation (GO:0007413) | 3.80501737 |
106 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.76762843 |
107 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.75995456 |
108 | progesterone metabolic process (GO:0042448) | 3.74594437 |
109 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.73804240 |
110 | neuron recognition (GO:0008038) | 3.73131350 |
111 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.70036563 |
112 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.70036563 |
113 | negative regulation of receptor activity (GO:2000272) | 3.65846761 |
114 | neuronal ion channel clustering (GO:0045161) | 3.63679013 |
115 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 3.61565691 |
116 | regulation of neurotransmitter levels (GO:0001505) | 3.61408854 |
117 | reproductive system development (GO:0061458) | 3.60707314 |
118 | regulation of neuron projection regeneration (GO:0070570) | 3.59494848 |
119 | regulation of axon regeneration (GO:0048679) | 3.59494848 |
120 | keratan sulfate catabolic process (GO:0042340) | 3.58429855 |
121 | protein localization to vacuole (GO:0072665) | 3.55052334 |
122 | protein localization to lysosome (GO:0061462) | 3.55052334 |
123 | regulation of beta-amyloid formation (GO:1902003) | 3.54910450 |
124 | protein localization to synapse (GO:0035418) | 3.54087176 |
125 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.50479925 |
126 | regulation of autophagic vacuole assembly (GO:2000785) | 3.50316649 |
127 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.47464925 |
128 | neuromuscular process controlling balance (GO:0050885) | 3.47280151 |
129 | axon ensheathment in central nervous system (GO:0032291) | 3.47079722 |
130 | central nervous system myelination (GO:0022010) | 3.47079722 |
131 | vesicle transport along microtubule (GO:0047496) | 3.45931140 |
132 | glycine transport (GO:0015816) | 3.44723112 |
133 | regulation of cellular respiration (GO:0043457) | 3.44161299 |
134 | potassium ion homeostasis (GO:0055075) | 3.41326136 |
135 | glutamate receptor signaling pathway (GO:0007215) | 3.38980085 |
136 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.38869533 |
137 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.37828754 |
138 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.36495176 |
139 | dendritic spine morphogenesis (GO:0060997) | 3.34624684 |
140 | long-term memory (GO:0007616) | 3.33896974 |
141 | regulation of cAMP-mediated signaling (GO:0043949) | 3.33514407 |
142 | L-amino acid import (GO:0043092) | 3.32390608 |
143 | synaptic vesicle endocytosis (GO:0048488) | 3.31690876 |
144 | melanin metabolic process (GO:0006582) | 3.30911962 |
145 | striated muscle adaptation (GO:0014888) | 3.30697099 |
146 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.30424114 |
147 | melanin biosynthetic process (GO:0042438) | 3.29757898 |
148 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26183216 |
149 | synaptic transmission, glutamatergic (GO:0035249) | 3.25013944 |
150 | dendrite morphogenesis (GO:0048813) | 3.23946247 |
151 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.20450809 |
152 | regulation of synapse structural plasticity (GO:0051823) | 3.19100105 |
153 | cellular sodium ion homeostasis (GO:0006883) | 3.17211064 |
154 | mating behavior (GO:0007617) | 3.17154846 |
155 | alanine transport (GO:0032328) | 3.17055762 |
156 | establishment of nucleus localization (GO:0040023) | 3.16768410 |
157 | cellular response to antibiotic (GO:0071236) | 3.15964201 |
158 | membrane depolarization during action potential (GO:0086010) | 3.13139122 |
159 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.11935976 |
160 | glucocorticoid metabolic process (GO:0008211) | 3.10624054 |
161 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.07697287 |
162 | transmission of nerve impulse (GO:0019226) | 3.07332830 |
163 | androgen metabolic process (GO:0008209) | 3.05400077 |
164 | steroid catabolic process (GO:0006706) | 3.04641318 |
165 | regulation of ARF protein signal transduction (GO:0032012) | 3.03676465 |
166 | organelle transport along microtubule (GO:0072384) | 3.03226173 |
167 | axon cargo transport (GO:0008088) | 3.03204350 |
168 | regulation of vacuole organization (GO:0044088) | 3.02283567 |
169 | neuropeptide signaling pathway (GO:0007218) | 3.02121752 |
170 | secondary metabolite biosynthetic process (GO:0044550) | 3.01513192 |
171 | heparin metabolic process (GO:0030202) | 3.00256947 |
172 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.98735096 |
173 | regulation of vesicle fusion (GO:0031338) | 2.98582686 |
174 | regulation of synaptic plasticity (GO:0048167) | 2.97693326 |
175 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.95720978 |
176 | positive regulation of membrane potential (GO:0045838) | 2.93978059 |
177 | postsynaptic membrane organization (GO:0001941) | 2.92290197 |
178 | neuron-neuron synaptic transmission (GO:0007270) | 2.90435311 |
179 | presynaptic membrane organization (GO:0097090) | 2.87557388 |
180 | acidic amino acid transport (GO:0015800) | 2.85075262 |
181 | response to auditory stimulus (GO:0010996) | 2.83958151 |
182 | adult walking behavior (GO:0007628) | 2.82226444 |
183 | cell communication involved in cardiac conduction (GO:0086065) | 2.80982139 |
184 | L-glutamate transport (GO:0015813) | 2.80882514 |
185 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.80410866 |
186 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.78432367 |
187 | regulation of neurotransmitter secretion (GO:0046928) | 2.77107703 |
188 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.76460060 |
189 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.75950674 |
190 | response to pheromone (GO:0019236) | 2.75582702 |
191 | neurotransmitter catabolic process (GO:0042135) | 2.73743015 |
192 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.70993883 |
193 | neuromuscular process (GO:0050905) | 2.70068677 |
194 | positive regulation of potassium ion transport (GO:0043268) | 2.70020978 |
195 | amino acid import (GO:0043090) | 2.63708555 |
196 | regulation of postsynaptic membrane potential (GO:0060078) | 2.63018288 |
197 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.62594353 |
198 | intraspecies interaction between organisms (GO:0051703) | 2.61763421 |
199 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 10.6735377 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.15468503 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75534943 |
3 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.07377335 |
4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.50580851 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.84630513 |
6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.71526930 |
7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.71175438 |
8 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.70284066 |
9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.69571737 |
10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.51342693 |
11 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.46107503 |
12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.45758214 |
13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.44909195 |
14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.43413005 |
15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43077976 |
16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.41803629 |
17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.41157421 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40843772 |
19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.40318580 |
20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.40318580 |
21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33428456 |
22 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.30565958 |
23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.26265051 |
24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26080546 |
25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.24783662 |
26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.19402189 |
27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.18109444 |
28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15804699 |
29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.15170749 |
30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13242013 |
31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11244152 |
32 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.06901856 |
33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.04824628 |
34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.01536145 |
35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99101115 |
36 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.97142038 |
37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96006960 |
38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.92133471 |
39 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.89402472 |
40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87968936 |
41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86320215 |
42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.81721490 |
43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.81467087 |
44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.80767624 |
45 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.79993230 |
46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.79477765 |
47 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.69056870 |
48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.67689135 |
49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58648200 |
50 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.56474135 |
51 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.56199566 |
52 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47833322 |
53 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.47633936 |
54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.46499290 |
55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42890446 |
56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.42247910 |
57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41601387 |
58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40679234 |
59 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39120049 |
60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38473403 |
61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38111016 |
62 | JUN_21703547_ChIP-Seq_K562_Human | 1.37549109 |
63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35781933 |
64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35233728 |
65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32770626 |
66 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.31484277 |
67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30233790 |
68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30190187 |
69 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30124066 |
70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.29767747 |
71 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29767747 |
72 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29154831 |
73 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27028484 |
74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26558876 |
75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25053257 |
76 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23131742 |
77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22815941 |
78 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22778617 |
79 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.21136480 |
80 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20359162 |
81 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.19631495 |
82 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.18454406 |
83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17627204 |
84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16455875 |
85 | AR_19668381_ChIP-Seq_PC3_Human | 1.16280463 |
86 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16207327 |
87 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16106002 |
88 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15925837 |
89 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.15925837 |
90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15808384 |
91 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.15476663 |
92 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15417335 |
93 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15036697 |
94 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14031188 |
95 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13526052 |
96 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.12859379 |
97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11375534 |
98 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11015244 |
99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10903816 |
100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10848195 |
101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10848195 |
102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10549366 |
103 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.10433302 |
104 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09206395 |
105 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08998751 |
106 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08178935 |
107 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07777293 |
108 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.07501180 |
109 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06111487 |
110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05536136 |
111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04729999 |
112 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04295114 |
113 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03260549 |
114 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02704345 |
115 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02492641 |
116 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02128086 |
117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01979641 |
118 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01799801 |
119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.01568419 |
120 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.01224064 |
121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01130138 |
122 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99727533 |
123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99693670 |
124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99305492 |
125 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98536372 |
126 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98514100 |
127 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97290379 |
128 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97270026 |
129 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96810432 |
130 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96408265 |
131 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96355651 |
132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96323539 |
133 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96078549 |
134 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95973498 |
135 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95868359 |
136 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95646666 |
137 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95557193 |
138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95252968 |
139 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94416646 |
140 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94026739 |
141 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93923214 |
142 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.93748172 |
143 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93498057 |
144 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93469349 |
145 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93327135 |
146 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93020476 |
147 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92919245 |
148 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92844386 |
149 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92700774 |
150 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92539609 |
151 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.91838257 |
152 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91738433 |
153 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90817826 |
154 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90623921 |
155 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87905086 |
156 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86646003 |
157 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86485478 |
158 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85699929 |
159 | P300_19829295_ChIP-Seq_ESCs_Human | 0.85615097 |
160 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85218612 |
161 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84898766 |
162 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84517707 |
163 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83836760 |
164 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83664346 |
165 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83379745 |
166 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82575510 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.25134858 |
2 | MP0003646_muscle_fatigue | 6.22637395 |
3 | MP0005187_abnormal_penis_morphology | 5.11545627 |
4 | MP0003880_abnormal_central_pattern | 4.78259558 |
5 | MP0003315_abnormal_perineum_morphology | 4.76049844 |
6 | MP0001919_abnormal_reproductive_system | 4.16946124 |
7 | MP0003635_abnormal_synaptic_transmissio | 3.80093813 |
8 | MP0005257_abnormal_intraocular_pressure | 3.69731351 |
9 | MP0005423_abnormal_somatic_nervous | 3.62767978 |
10 | MP0001968_abnormal_touch/_nociception | 3.24159780 |
11 | MP0009745_abnormal_behavioral_response | 3.16720370 |
12 | MP0002064_seizures | 3.15056312 |
13 | MP0004270_analgesia | 3.08658721 |
14 | MP0003122_maternal_imprinting | 2.89919682 |
15 | MP0009046_muscle_twitch | 2.78949386 |
16 | * MP0000631_abnormal_neuroendocrine_gland | 2.77966245 |
17 | MP0002063_abnormal_learning/memory/cond | 2.73270690 |
18 | MP0002971_abnormal_brown_adipose | 2.66935835 |
19 | MP0008995_early_reproductive_senescence | 2.59678128 |
20 | MP0005647_abnormal_sex_gland | 2.57678503 |
21 | MP0005171_absent_coat_pigmentation | 2.52699445 |
22 | MP0005389_reproductive_system_phenotype | 2.52574280 |
23 | MP0005408_hypopigmentation | 2.29701413 |
24 | MP0005451_abnormal_body_composition | 2.26791494 |
25 | MP0002572_abnormal_emotion/affect_behav | 2.26525930 |
26 | MP0001529_abnormal_vocalization | 2.24568272 |
27 | MP0001501_abnormal_sleep_pattern | 2.24314734 |
28 | MP0002272_abnormal_nervous_system | 2.22740275 |
29 | MP0003329_amyloid_beta_deposits | 2.20535028 |
30 | MP0002909_abnormal_adrenal_gland | 2.18235387 |
31 | MP0004885_abnormal_endolymph | 2.11692802 |
32 | MP0003690_abnormal_glial_cell | 2.10297190 |
33 | MP0009780_abnormal_chondrocyte_physiolo | 2.09864022 |
34 | MP0002734_abnormal_mechanical_nocicepti | 2.03883438 |
35 | MP0001486_abnormal_startle_reflex | 2.00356079 |
36 | MP0005645_abnormal_hypothalamus_physiol | 1.96420387 |
37 | MP0000569_abnormal_digit_pigmentation | 1.95086402 |
38 | MP0003183_abnormal_peptide_metabolism | 1.94657930 |
39 | MP0004858_abnormal_nervous_system | 1.91524301 |
40 | MP0003787_abnormal_imprinting | 1.89719509 |
41 | MP0000372_irregular_coat_pigmentation | 1.85123738 |
42 | MP0001542_abnormal_bone_strength | 1.80443446 |
43 | MP0002733_abnormal_thermal_nociception | 1.79612034 |
44 | MP0003123_paternal_imprinting | 1.70537661 |
45 | MP0004811_abnormal_neuron_physiology | 1.70117068 |
46 | MP0001440_abnormal_grooming_behavior | 1.68721687 |
47 | MP0002067_abnormal_sensory_capabilities | 1.68134730 |
48 | MP0003172_abnormal_lysosome_physiology | 1.66061968 |
49 | MP0008569_lethality_at_weaning | 1.64047880 |
50 | MP0002736_abnormal_nociception_after | 1.63799298 |
51 | MP0003283_abnormal_digestive_organ | 1.63032736 |
52 | MP0000751_myopathy | 1.62733806 |
53 | MP0001970_abnormal_pain_threshold | 1.60690619 |
54 | MP0003633_abnormal_nervous_system | 1.54989359 |
55 | MP0005085_abnormal_gallbladder_physiolo | 1.51798917 |
56 | MP0000778_abnormal_nervous_system | 1.48017300 |
57 | MP0008260_abnormal_autophagy | 1.47146555 |
58 | MP0000955_abnormal_spinal_cord | 1.44925423 |
59 | MP0000920_abnormal_myelination | 1.44555170 |
60 | * MP0005646_abnormal_pituitary_gland | 1.42258003 |
61 | MP0002557_abnormal_social/conspecific_i | 1.38661559 |
62 | MP0005386_behavior/neurological_phenoty | 1.38602570 |
63 | MP0004924_abnormal_behavior | 1.38602570 |
64 | MP0002269_muscular_atrophy | 1.37125315 |
65 | MP0002184_abnormal_innervation | 1.36985408 |
66 | MP0002735_abnormal_chemical_nociception | 1.33302319 |
67 | MP0005623_abnormal_meninges_morphology | 1.32301710 |
68 | MP0002066_abnormal_motor_capabilities/c | 1.31482760 |
69 | MP0006276_abnormal_autonomic_nervous | 1.28883045 |
70 | MP0000604_amyloidosis | 1.26645503 |
71 | MP0008961_abnormal_basal_metabolism | 1.24302413 |
72 | MP0003631_nervous_system_phenotype | 1.23842592 |
73 | MP0003075_altered_response_to | 1.19683427 |
74 | MP0002970_abnormal_white_adipose | 1.18234399 |
75 | MP0002882_abnormal_neuron_morphology | 1.16035391 |
76 | MP0000013_abnormal_adipose_tissue | 1.13283981 |
77 | MP0001177_atelectasis | 1.09973109 |
78 | MP0003632_abnormal_nervous_system | 1.08750928 |
79 | MP0005075_abnormal_melanosome_morpholog | 1.08550578 |
80 | MP0003634_abnormal_glial_cell | 1.07576083 |
81 | MP0004142_abnormal_muscle_tone | 1.07291284 |
82 | MP0003121_genomic_imprinting | 1.05669306 |
83 | MP0004145_abnormal_muscle_electrophysio | 1.05360487 |
84 | MP0005058_abnormal_lysosome_morphology | 1.02920095 |
85 | MP0010234_abnormal_vibrissa_follicle | 1.02498657 |
86 | MP0004484_altered_response_of | 1.01272707 |
87 | MP0006138_congestive_heart_failure | 1.00116512 |
88 | MP0004043_abnormal_pH_regulation | 0.99538058 |
89 | MP0005167_abnormal_blood-brain_barrier | 0.98396446 |
90 | MP0002229_neurodegeneration | 0.98323083 |
91 | MP0001324_abnormal_eye_pigmentation | 0.97038581 |
92 | MP0008874_decreased_physiological_sensi | 0.96460328 |
93 | MP0002837_dystrophic_cardiac_calcinosis | 0.95927694 |
94 | MP0002332_abnormal_exercise_endurance | 0.94367654 |
95 | * MP0001905_abnormal_dopamine_level | 0.92801935 |
96 | MP0001502_abnormal_circadian_rhythm | 0.92164180 |
97 | MP0000747_muscle_weakness | 0.90454205 |
98 | * MP0002152_abnormal_brain_morphology | 0.90087299 |
99 | MP0002069_abnormal_eating/drinking_beha | 0.87800113 |
100 | MP0000681_abnormal_thyroid_gland | 0.87315841 |
101 | MP0001299_abnormal_eye_distance/ | 0.84792954 |
102 | MP0009115_abnormal_fat_cell | 0.84436604 |
103 | MP0003195_calcinosis | 0.83282269 |
104 | MP0004130_abnormal_muscle_cell | 0.81897151 |
105 | MP0003806_abnormal_nucleotide_metabolis | 0.80678278 |
106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80152936 |
107 | MP0003879_abnormal_hair_cell | 0.80071114 |
108 | MP0005535_abnormal_body_temperature | 0.79463322 |
109 | MP0008872_abnormal_physiological_respon | 0.78392513 |
110 | MP0003950_abnormal_plasma_membrane | 0.77377054 |
111 | MP0005334_abnormal_fat_pad | 0.76410444 |
112 | MP0000371_diluted_coat_color | 0.75728142 |
113 | MP0003137_abnormal_impulse_conducting | 0.74999098 |
114 | MP0002638_abnormal_pupillary_reflex | 0.72915197 |
115 | MP0002095_abnormal_skin_pigmentation | 0.72623097 |
116 | MP0009840_abnormal_foam_cell | 0.71740460 |
117 | MP0000639_abnormal_adrenal_gland | 0.70253777 |
118 | MP0004085_abnormal_heartbeat | 0.70244687 |
119 | MP0002089_abnormal_postnatal_growth/wei | 0.70026488 |
120 | MP0003045_fibrosis | 0.66245126 |
121 | MP0005165_increased_susceptibility_to | 0.65789121 |
122 | MP0005551_abnormal_eye_electrophysiolog | 0.65609098 |
123 | MP0000015_abnormal_ear_pigmentation | 0.63341924 |
124 | MP0005266_abnormal_metabolism | 0.58668704 |
125 | MP0004233_abnormal_muscle_weight | 0.58413455 |
126 | MP0001984_abnormal_olfaction | 0.58340938 |
127 | MP0001348_abnormal_lacrimal_gland | 0.58005874 |
128 | MP0005360_urolithiasis | 0.57179383 |
129 | MP0002822_catalepsy | 0.56945221 |
130 | MP0002078_abnormal_glucose_homeostasis | 0.56730936 |
131 | MP0003953_abnormal_hormone_level | 0.56430572 |
132 | MP0002139_abnormal_hepatobiliary_system | 0.56406018 |
133 | MP0005448_abnormal_energy_balance | 0.55996777 |
134 | MP0001943_abnormal_respiration | 0.54487447 |
135 | MP0010386_abnormal_urinary_bladder | 0.53764698 |
136 | MP0005197_abnormal_uvea_morphology | 0.53727345 |
137 | MP0001186_pigmentation_phenotype | 0.53530755 |
138 | MP0005379_endocrine/exocrine_gland_phen | 0.53392278 |
139 | MP0010769_abnormal_survival | 0.52831974 |
140 | MP0010770_preweaning_lethality | 0.52243156 |
141 | MP0002082_postnatal_lethality | 0.52243156 |
142 | MP0005166_decreased_susceptibility_to | 0.52060305 |
143 | MP0004215_abnormal_myocardial_fiber | 0.51431310 |
144 | MP0002090_abnormal_vision | 0.51230173 |
145 | MP0003786_premature_aging | 0.50201553 |
146 | MP0006036_abnormal_mitochondrial_physio | 0.48941294 |
147 | MP0002075_abnormal_coat/hair_pigmentati | 0.48247396 |
148 | MP0008770_decreased_survivor_rate | 0.47882532 |
149 | MP0001119_abnormal_female_reproductive | 0.47561840 |
150 | MP0002106_abnormal_muscle_physiology | 0.47403722 |
151 | MP0005332_abnormal_amino_acid | 0.46562649 |
152 | MP0003959_abnormal_lean_body | 0.45987748 |
153 | MP0000647_abnormal_sebaceous_gland | 0.45735464 |
154 | MP0005620_abnormal_muscle_contractility | 0.42462392 |
155 | MP0004381_abnormal_hair_follicle | 0.40748551 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Enlarged penis (HP:0000040) | 9.89758563 |
2 | Gonadotropin excess (HP:0000837) | 9.30948491 |
3 | Asymmetric septal hypertrophy (HP:0001670) | 9.26170852 |
4 | Neonatal hypoglycemia (HP:0001998) | 8.99066896 |
5 | Focal motor seizures (HP:0011153) | 5.85800061 |
6 | Bundle branch block (HP:0011710) | 5.75258778 |
7 | Absent frontal sinuses (HP:0002688) | 5.20156559 |
8 | Atrioventricular block (HP:0001678) | 5.16431733 |
9 | Myokymia (HP:0002411) | 5.05567033 |
10 | Visual hallucinations (HP:0002367) | 4.89230953 |
11 | Focal seizures (HP:0007359) | 4.85508585 |
12 | Papilledema (HP:0001085) | 4.71044325 |
13 | Supranuclear gaze palsy (HP:0000605) | 4.61335882 |
14 | Spondylolisthesis (HP:0003302) | 4.32136874 |
15 | Testicular neoplasm (HP:0010788) | 4.28721859 |
16 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.98769696 |
17 | Persistence of primary teeth (HP:0006335) | 3.90098365 |
18 | Abnormal eating behavior (HP:0100738) | 3.89485605 |
19 | Absence seizures (HP:0002121) | 3.81264876 |
20 | Autoamputation (HP:0001218) | 3.76130463 |
21 | Osteolytic defects of the hand bones (HP:0009699) | 3.74551167 |
22 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.74551167 |
23 | Generalized tonic-clonic seizures (HP:0002069) | 3.71670041 |
24 | Hypoglycemic seizures (HP:0002173) | 3.66632527 |
25 | Abnormality of the anterior horn cell (HP:0006802) | 3.65607638 |
26 | Degeneration of anterior horn cells (HP:0002398) | 3.65607638 |
27 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.63854210 |
28 | Hypokalemic alkalosis (HP:0001949) | 3.59460330 |
29 | Atonic seizures (HP:0010819) | 3.57971893 |
30 | Hypergonadotropic hypogonadism (HP:0000815) | 3.55880103 |
31 | Neurofibrillary tangles (HP:0002185) | 3.50002568 |
32 | Ankle clonus (HP:0011448) | 3.46649388 |
33 | Postural instability (HP:0002172) | 3.46063040 |
34 | Palpitations (HP:0001962) | 3.45827035 |
35 | Depression (HP:0000716) | 3.45715361 |
36 | Action tremor (HP:0002345) | 3.43139240 |
37 | Ventricular fibrillation (HP:0001663) | 3.38165840 |
38 | Bradycardia (HP:0001662) | 3.36811954 |
39 | Dialeptic seizures (HP:0011146) | 3.33651343 |
40 | Cerebral inclusion bodies (HP:0100314) | 3.33403652 |
41 | Epileptic encephalopathy (HP:0200134) | 3.32089365 |
42 | Mutism (HP:0002300) | 3.25056921 |
43 | Hemiplegia (HP:0002301) | 3.24091786 |
44 | Abnormality of glycolipid metabolism (HP:0010969) | 3.20896733 |
45 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.20896733 |
46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.20896733 |
47 | Abnormality of the frontal sinuses (HP:0002687) | 3.13294923 |
48 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.12707990 |
49 | Progressive cerebellar ataxia (HP:0002073) | 3.11577967 |
50 | Agitation (HP:0000713) | 3.11541507 |
51 | Abnormality of the lower motor neuron (HP:0002366) | 3.09916245 |
52 | Heart block (HP:0012722) | 3.04880877 |
53 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.99747212 |
54 | Anxiety (HP:0000739) | 2.93806168 |
55 | Spinal muscular atrophy (HP:0007269) | 2.92220562 |
56 | Abnormal atrioventricular conduction (HP:0005150) | 2.89085273 |
57 | Insomnia (HP:0100785) | 2.85597797 |
58 | Intention tremor (HP:0002080) | 2.85389894 |
59 | Hammertoe (HP:0001765) | 2.81566647 |
60 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.81378177 |
61 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.81378177 |
62 | Dysmetria (HP:0001310) | 2.79713836 |
63 | Cerebral aneurysm (HP:0004944) | 2.79624707 |
64 | Febrile seizures (HP:0002373) | 2.77970598 |
65 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.77812862 |
66 | Ridged nail (HP:0001807) | 2.74222412 |
67 | Proximal tubulopathy (HP:0000114) | 2.73236718 |
68 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.72307357 |
69 | Dysdiadochokinesis (HP:0002075) | 2.71733074 |
70 | Impaired social interactions (HP:0000735) | 2.70234182 |
71 | Abnormal social behavior (HP:0012433) | 2.70234182 |
72 | Progressive inability to walk (HP:0002505) | 2.68652186 |
73 | Spastic gait (HP:0002064) | 2.68276282 |
74 | Generalized aminoaciduria (HP:0002909) | 2.67631130 |
75 | Pheochromocytoma (HP:0002666) | 2.66433400 |
76 | Macroorchidism (HP:0000053) | 2.59748777 |
77 | Truncal ataxia (HP:0002078) | 2.59567882 |
78 | Steppage gait (HP:0003376) | 2.59001678 |
79 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.58492140 |
80 | Hyperpituitarism (HP:0010514) | 2.54916633 |
81 | Status epilepticus (HP:0002133) | 2.54900227 |
82 | Urinary urgency (HP:0000012) | 2.54665783 |
83 | Torticollis (HP:0000473) | 2.54240463 |
84 | Poor eye contact (HP:0000817) | 2.54162186 |
85 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.47876288 |
86 | Hemiparesis (HP:0001269) | 2.47192254 |
87 | Renal cortical cysts (HP:0000803) | 2.46318641 |
88 | Acne (HP:0001061) | 2.44820085 |
89 | Symptomatic seizures (HP:0011145) | 2.44790809 |
90 | Tongue fasciculations (HP:0001308) | 2.42067980 |
91 | Bradykinesia (HP:0002067) | 2.41835912 |
92 | Cardiomegaly (HP:0001640) | 2.39986711 |
93 | Abnormality of proline metabolism (HP:0010907) | 2.39220008 |
94 | Hydroxyprolinuria (HP:0003080) | 2.39220008 |
95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37713517 |
96 | Mucopolysacchariduria (HP:0008155) | 2.37713517 |
97 | Abnormality of the corticospinal tract (HP:0002492) | 2.36348536 |
98 | Psychosis (HP:0000709) | 2.36275031 |
99 | Syringomyelia (HP:0003396) | 2.36157905 |
100 | Spinal cord lesions (HP:0100561) | 2.36157905 |
101 | Rapidly progressive (HP:0003678) | 2.33577495 |
102 | Lower limb muscle weakness (HP:0007340) | 2.32967556 |
103 | Insidious onset (HP:0003587) | 2.31957698 |
104 | Termporal pattern (HP:0011008) | 2.31957698 |
105 | Abnormality of the periventricular white matter (HP:0002518) | 2.31763390 |
106 | Peripheral hypomyelination (HP:0007182) | 2.31488630 |
107 | Accelerated skeletal maturation (HP:0005616) | 2.30041475 |
108 | Neuronal loss in central nervous system (HP:0002529) | 2.28580075 |
109 | Alacrima (HP:0000522) | 2.28268649 |
110 | Excessive salivation (HP:0003781) | 2.26177015 |
111 | Drooling (HP:0002307) | 2.26177015 |
112 | Hypercortisolism (HP:0001578) | 2.26161711 |
113 | Polyphagia (HP:0002591) | 2.23680164 |
114 | Scanning speech (HP:0002168) | 2.23273647 |
115 | Neuroendocrine neoplasm (HP:0100634) | 2.23092944 |
116 | Abnormality of binocular vision (HP:0011514) | 2.23017960 |
117 | Diplopia (HP:0000651) | 2.23017960 |
118 | Focal dystonia (HP:0004373) | 2.22031845 |
119 | Genetic anticipation (HP:0003743) | 2.21904864 |
120 | Broad-based gait (HP:0002136) | 2.21715331 |
121 | Generalized hypopigmentation (HP:0007513) | 2.19725941 |
122 | Hoarse voice (HP:0001609) | 2.16793519 |
123 | Muscle fibrillation (HP:0010546) | 2.15962469 |
124 | Clonus (HP:0002169) | 2.15517727 |
125 | Emotional lability (HP:0000712) | 2.14690814 |
126 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12299588 |
127 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12299588 |
128 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12299588 |
129 | Dysostosis multiplex (HP:0000943) | 2.10971381 |
130 | Turricephaly (HP:0000262) | 2.10161816 |
131 | Rigidity (HP:0002063) | 2.09526700 |
132 | Craniofacial dystonia (HP:0012179) | 2.07940624 |
133 | Dementia (HP:0000726) | 2.03567329 |
134 | Generalized myoclonic seizures (HP:0002123) | 2.02286299 |
135 | Frequent falls (HP:0002359) | 2.01934737 |
136 | Bronchomalacia (HP:0002780) | 2.01019767 |
137 | Attention deficit hyperactivity disorder (HP:0007018) | 1.99770265 |
138 | Lower limb amyotrophy (HP:0007210) | 1.98575717 |
139 | Increased circulating renin level (HP:0000848) | 1.98504317 |
140 | Generalized hypopigmentation of hair (HP:0011358) | 1.98215332 |
141 | Foot dorsiflexor weakness (HP:0009027) | 1.96822519 |
142 | Neoplasm of the heart (HP:0100544) | 1.96525892 |
143 | Ulnar claw (HP:0001178) | 1.96121899 |
144 | Aplasia involving bones of the extremities (HP:0009825) | 1.94139038 |
145 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.94139038 |
146 | Aplasia of the phalanges of the hand (HP:0009802) | 1.94139038 |
147 | Impaired smooth pursuit (HP:0007772) | 1.93695778 |
148 | Palpebral edema (HP:0100540) | 1.93234345 |
149 | Abnormality of the foot musculature (HP:0001436) | 1.92858211 |
150 | Hypoventilation (HP:0002791) | 1.92384684 |
151 | Hyperventilation (HP:0002883) | 1.92060901 |
152 | Ovoid vertebral bodies (HP:0003300) | 1.91953047 |
153 | Atrial fibrillation (HP:0005110) | 1.91182597 |
154 | Decreased lacrimation (HP:0000633) | 1.90872367 |
155 | Abnormal EKG (HP:0003115) | 1.90636572 |
156 | Ventricular arrhythmia (HP:0004308) | 1.89482561 |
157 | Tetraplegia (HP:0002445) | 1.89441573 |
158 | Fetal akinesia sequence (HP:0001989) | 1.89186983 |
159 | Failure to thrive in infancy (HP:0001531) | 1.88801977 |
160 | Striae distensae (HP:0001065) | 1.86532548 |
161 | Postural tremor (HP:0002174) | 1.86484846 |
162 | Restlessness (HP:0000711) | 1.86062309 |
163 | Hyperacusis (HP:0010780) | 1.84265342 |
164 | Nausea (HP:0002018) | 1.83660695 |
165 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83496739 |
166 | Male infertility (HP:0003251) | 1.83137196 |
167 | Primary atrial arrhythmia (HP:0001692) | 1.82974680 |
168 | Menstrual irregularities (HP:0000858) | 1.81565916 |
169 | Epileptiform EEG discharges (HP:0011182) | 1.80870261 |
170 | Blue irides (HP:0000635) | 1.80124047 |
171 | Hypsarrhythmia (HP:0002521) | 1.79386841 |
172 | Spastic paraplegia (HP:0001258) | 1.78577081 |
173 | Megalencephaly (HP:0001355) | 1.78044446 |
174 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.77241733 |
175 | Pointed chin (HP:0000307) | 1.77208591 |
176 | Supraventricular tachycardia (HP:0004755) | 1.76364522 |
177 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.75301478 |
178 | Stroke (HP:0001297) | 1.74820437 |
179 | Decreased motor nerve conduction velocity (HP:0003431) | 1.74797151 |
180 | Hypoglycemic coma (HP:0001325) | 1.74110692 |
181 | Supraventricular arrhythmia (HP:0005115) | 1.72554855 |
182 | Decreased testicular size (HP:0008734) | 1.71661066 |
183 | Abnormality of complement system (HP:0005339) | 1.71089190 |
184 | Cerebral palsy (HP:0100021) | 1.71037516 |
185 | Paraplegia (HP:0010550) | 1.71020469 |
186 | Alkalosis (HP:0001948) | 1.70490356 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 5.17007158 |
2 | EEF2K | 4.90353885 |
3 | MAPKAPK3 | 4.87530950 |
4 | TRPM7 | 4.26326075 |
5 | MAP3K9 | 3.46787384 |
6 | WNK3 | 3.12930883 |
7 | MAP3K4 | 3.03115795 |
8 | PRKAA2 | 2.98097657 |
9 | ZAK | 2.85576172 |
10 | EIF2AK3 | 2.84852903 |
11 | MARK1 | 2.82566420 |
12 | PAK6 | 2.78450735 |
13 | MUSK | 2.76312680 |
14 | DYRK3 | 2.67216551 |
15 | MINK1 | 2.54640742 |
16 | MAP3K12 | 2.51489652 |
17 | MAP2K4 | 2.40437065 |
18 | BMPR1B | 2.35931489 |
19 | NTRK2 | 2.35102689 |
20 | NTRK1 | 2.32249890 |
21 | KSR2 | 2.21344469 |
22 | UHMK1 | 2.08073966 |
23 | CCNB1 | 2.07946854 |
24 | EPHA4 | 2.03175795 |
25 | AKT2 | 1.97061518 |
26 | MAP2K7 | 1.91891584 |
27 | TNIK | 1.85987727 |
28 | ALK | 1.75593611 |
29 | NLK | 1.73426984 |
30 | MAPKAPK5 | 1.69013033 |
31 | CSNK1A1L | 1.59991939 |
32 | TAF1 | 1.57544641 |
33 | ACVR1B | 1.57166086 |
34 | LMTK2 | 1.54678777 |
35 | PRKD3 | 1.54428361 |
36 | FES | 1.54036778 |
37 | PAK3 | 1.52544104 |
38 | CAMKK1 | 1.52284894 |
39 | CDK5 | 1.51083475 |
40 | PRKCH | 1.50717477 |
41 | STK38 | 1.46633630 |
42 | SCYL2 | 1.44600761 |
43 | CSNK1G3 | 1.43452979 |
44 | MAPK12 | 1.40754626 |
45 | AKT3 | 1.39536412 |
46 | BCR | 1.36091138 |
47 | MAP3K2 | 1.35522163 |
48 | LATS2 | 1.34283055 |
49 | FRK | 1.31927825 |
50 | TAOK3 | 1.31880354 |
51 | MAP3K13 | 1.31187869 |
52 | RIPK4 | 1.30756157 |
53 | MAP3K6 | 1.27231165 |
54 | CSNK1G1 | 1.18349554 |
55 | PHKG2 | 1.18130155 |
56 | PHKG1 | 1.18130155 |
57 | SIK2 | 1.16747878 |
58 | GRK5 | 1.16502755 |
59 | CDK19 | 1.16289929 |
60 | TIE1 | 1.13062290 |
61 | DAPK2 | 1.12567261 |
62 | CDC42BPA | 1.10329948 |
63 | RIPK1 | 1.08935393 |
64 | RET | 1.04581250 |
65 | NEK9 | 1.03419901 |
66 | RPS6KB2 | 1.03233785 |
67 | PRKCG | 1.01739538 |
68 | OBSCN | 1.00242332 |
69 | CAMK1G | 0.97891624 |
70 | MAPK13 | 0.97560796 |
71 | SGK494 | 0.95741840 |
72 | SGK223 | 0.95741840 |
73 | EPHA3 | 0.95143976 |
74 | KSR1 | 0.94143492 |
75 | NEK1 | 0.89724216 |
76 | PLK2 | 0.87580060 |
77 | ERBB3 | 0.86669677 |
78 | TYRO3 | 0.84748899 |
79 | FER | 0.82379885 |
80 | PNCK | 0.82371051 |
81 | SGK3 | 0.82200709 |
82 | MAP3K1 | 0.80948619 |
83 | CAMK2A | 0.80361775 |
84 | CAMK1 | 0.80065725 |
85 | PKN2 | 0.76298174 |
86 | FLT3 | 0.75859437 |
87 | CDK15 | 0.74978746 |
88 | BMPR2 | 0.73090950 |
89 | CDK14 | 0.72248543 |
90 | CDK18 | 0.71795526 |
91 | TNK2 | 0.70893315 |
92 | CAMK2B | 0.69694276 |
93 | DDR2 | 0.69487661 |
94 | PDGFRA | 0.68553170 |
95 | MAP3K7 | 0.67603926 |
96 | WNK1 | 0.67283089 |
97 | ROCK2 | 0.66753178 |
98 | STK11 | 0.66339922 |
99 | SGK2 | 0.65311815 |
100 | PDK1 | 0.65067207 |
101 | RPS6KA3 | 0.63047152 |
102 | CSNK1G2 | 0.62684537 |
103 | BMX | 0.62189032 |
104 | MAPK10 | 0.61824752 |
105 | PRKAA1 | 0.61666763 |
106 | CDK11A | 0.61551509 |
107 | CDK6 | 0.60800098 |
108 | OXSR1 | 0.59420064 |
109 | ERBB2 | 0.57565643 |
110 | CAMK2D | 0.57178784 |
111 | CDK8 | 0.56035595 |
112 | EPHB1 | 0.55836059 |
113 | PDPK1 | 0.55277564 |
114 | FYN | 0.54301619 |
115 | SGK1 | 0.53679542 |
116 | DMPK | 0.53266673 |
117 | TAOK1 | 0.53058570 |
118 | CAMK2G | 0.52864407 |
119 | ARAF | 0.52499109 |
120 | IGF1R | 0.51160453 |
121 | PRKG1 | 0.50923980 |
122 | CAMK1D | 0.50316253 |
123 | JAK3 | 0.49602216 |
124 | ROCK1 | 0.49032860 |
125 | PRKD1 | 0.48282590 |
126 | MAPK11 | 0.47441852 |
127 | PRPF4B | 0.46493196 |
128 | MAPK7 | 0.44891237 |
129 | RPS6KA2 | 0.44768760 |
130 | FGFR2 | 0.43786297 |
131 | RAF1 | 0.42896703 |
132 | INSRR | 0.42659653 |
133 | JAK2 | 0.42129292 |
134 | PRKACA | 0.40866968 |
135 | PRKCZ | 0.40395025 |
136 | PRKACG | 0.40313224 |
137 | SRC | 0.38016508 |
138 | JAK1 | 0.37919766 |
139 | TEC | 0.37720443 |
140 | PRKCB | 0.37034806 |
141 | MELK | 0.36980456 |
142 | LIMK1 | 0.36603636 |
143 | PINK1 | 0.36590372 |
144 | DAPK1 | 0.36512315 |
145 | TRIB3 | 0.36060098 |
146 | DYRK1A | 0.35696896 |
147 | HIPK2 | 0.34784947 |
148 | TESK1 | 0.34714416 |
149 | PRKCE | 0.34236457 |
150 | PLK3 | 0.34179653 |
151 | MAP3K11 | 0.34060024 |
152 | ICK | 0.33206074 |
153 | RPS6KB1 | 0.32714418 |
154 | MAPK4 | 0.32505380 |
155 | MARK2 | 0.32312060 |
156 | FGFR3 | 0.31958807 |
157 | MAPK3 | 0.31682098 |
158 | PKN1 | 0.29793764 |
159 | KIT | 0.29246738 |
160 | CASK | 0.28304971 |
161 | CSNK1D | 0.26251961 |
162 | CLK1 | 0.25610505 |
163 | CDK4 | 0.25513478 |
164 | TGFBR2 | 0.23942004 |
165 | MAPK8 | 0.21569257 |
166 | PDGFRB | 0.18829120 |
167 | ADRBK1 | 0.18361965 |
168 | KDR | 0.18351676 |
169 | PRKACB | 0.17424345 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.46454630 |
2 | Circadian rhythm_Homo sapiens_hsa04710 | 4.44037646 |
3 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 3.75898269 |
4 | Lysosome_Homo sapiens_hsa04142 | 3.39900398 |
5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.33002417 |
6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.22852361 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15199431 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 3.11086544 |
9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.95728610 |
10 | ABC transporters_Homo sapiens_hsa02010 | 2.71302970 |
11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.53376784 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.53141977 |
13 | Circadian entrainment_Homo sapiens_hsa04713 | 2.31310538 |
14 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.26765197 |
15 | Allograft rejection_Homo sapiens_hsa05330 | 2.19329461 |
16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19138666 |
17 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 2.16836799 |
18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.16696908 |
19 | Morphine addiction_Homo sapiens_hsa05032 | 2.14013760 |
20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.11700740 |
21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.11187974 |
22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.10567211 |
23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.10379693 |
24 | Long-term potentiation_Homo sapiens_hsa04720 | 2.07938331 |
25 | Sulfur relay system_Homo sapiens_hsa04122 | 2.05945794 |
26 | Olfactory transduction_Homo sapiens_hsa04740 | 2.03999265 |
27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98872772 |
28 | Salivary secretion_Homo sapiens_hsa04970 | 1.92407075 |
29 | Insulin secretion_Homo sapiens_hsa04911 | 1.92216118 |
30 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.91912439 |
31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83744708 |
32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.81810673 |
33 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.76742765 |
34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75004077 |
35 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.69770564 |
36 | Phagosome_Homo sapiens_hsa04145 | 1.61970229 |
37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.61882449 |
38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.54674217 |
39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53443104 |
40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49435810 |
41 | Renin secretion_Homo sapiens_hsa04924 | 1.46647814 |
42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.45286554 |
43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.43993878 |
44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39684492 |
45 | Bile secretion_Homo sapiens_hsa04976 | 1.39060873 |
46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.37137377 |
47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.36419616 |
48 | Insulin resistance_Homo sapiens_hsa04931 | 1.32787117 |
49 | Taste transduction_Homo sapiens_hsa04742 | 1.32665883 |
50 | Long-term depression_Homo sapiens_hsa04730 | 1.27644178 |
51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20384671 |
52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20072309 |
53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18163814 |
54 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.13771689 |
55 | Gap junction_Homo sapiens_hsa04540 | 1.13473677 |
56 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12929826 |
57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10799035 |
58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.07562249 |
59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06590653 |
60 | Prion diseases_Homo sapiens_hsa05020 | 1.04829620 |
61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03996314 |
62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03902082 |
63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02642709 |
64 | Apoptosis_Homo sapiens_hsa04210 | 1.01725725 |
65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00999540 |
66 | Axon guidance_Homo sapiens_hsa04360 | 1.00094533 |
67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97799426 |
68 | Melanogenesis_Homo sapiens_hsa04916 | 0.95427387 |
69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94456836 |
70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92723498 |
71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91454528 |
72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90890614 |
73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.90817914 |
74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90369993 |
75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86585309 |
76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84473368 |
77 | Glioma_Homo sapiens_hsa05214 | 0.83063170 |
78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82556117 |
79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79702914 |
80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78417142 |
81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77378488 |
82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74373303 |
83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73742744 |
84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72251892 |
85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71404007 |
86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70364771 |
87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69975709 |
88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68366319 |
89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68142733 |
90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67634605 |
91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67162355 |
92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66492873 |
93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65779591 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65516724 |
95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65502731 |
96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64956381 |
97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64579007 |
98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63505050 |
99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63292504 |
100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62690699 |
101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62298144 |
102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61296177 |
103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59643519 |
104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59638308 |
105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55611165 |
106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54807466 |
107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54742838 |
108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52467308 |
109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50832321 |
110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49764588 |
111 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48949751 |
112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48798450 |
113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47856045 |
114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47061141 |
115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44225809 |
116 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43907879 |
117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43720778 |
118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42890004 |
119 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39711813 |
120 | Endocytosis_Homo sapiens_hsa04144 | 0.38858989 |
121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38089678 |
122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35953464 |
123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.35700899 |
124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.35339269 |
125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35085230 |
126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35026419 |
127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34519728 |
128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34489135 |
129 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33717652 |
130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33436710 |
131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33392931 |
132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32833064 |
133 | Lysine degradation_Homo sapiens_hsa00310 | 0.32627354 |
134 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29715515 |
135 | Tuberculosis_Homo sapiens_hsa05152 | 0.29691725 |
136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29606044 |
137 | Platelet activation_Homo sapiens_hsa04611 | 0.29139859 |
138 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28763692 |
139 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27999955 |
140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27519086 |
141 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27387191 |
142 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26637750 |
143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25190538 |
144 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24690219 |
145 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24185653 |
146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24080986 |
147 | Colorectal cancer_Homo sapiens_hsa05210 | 0.23374178 |
148 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23347632 |
149 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.22648769 |
150 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22348587 |
151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21838046 |
152 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.20626223 |
153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20301328 |
154 | Amoebiasis_Homo sapiens_hsa05146 | 0.20237976 |
155 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.14792218 |
156 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.14033707 |
157 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.13161908 |
158 | Salmonella infection_Homo sapiens_hsa05132 | 0.12165476 |
159 | Adherens junction_Homo sapiens_hsa04520 | 0.11072083 |
160 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.09073032 |
161 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.08937214 |
162 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.08213127 |
163 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.07771161 |
164 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.05380826 |
165 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.04479626 |